These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6236680)

  • 1. Benoxaprofen activation of suppressor activity in mononuclear leucocytes by a pro-oxidative mechanism in vitro.
    Eftychis H; Anderson R
    Agents Actions; 1984 Jun; 14(5-6):649-53. PubMed ID: 6236680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of induction of suppressor activity in human mononuclear leukocytes by ascorbate and cysteine in vitro.
    Eftychis H; Anderson R
    Int J Vitam Nutr Res; 1983; 53(4):398-401. PubMed ID: 6230331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benoxaprofen: a pro-oxidant anti-inflammatory drug?
    Anderson R; Lukey PT; Naudé SP; Jooné G
    Agents Actions; 1984 Feb; 14(2):238-46. PubMed ID: 6324560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the generation of reactive oxidants by human phagocytes during exposure to benoxaprofen and ultraviolet radiation in vitro.
    Anderson R; Eftychis HA
    Br J Dermatol; 1986 Sep; 115(3):285-95. PubMed ID: 3019378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of polymorphonuclear leucocyte motility by benoxaprofen related to activation of cellular oxidative metabolism.
    Anderson R; Jooné G
    Int J Immunopharmacol; 1984; 6(4):269-74. PubMed ID: 6480193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of DNA strand breaks in cocultured mononuclear leukocytes by protein kinase C-dependent prooxidative interactions of benoxaprofen, human polymorphonuclear leukocytes, and ultraviolet radiation.
    Schwalb G; Beyers AD; Anderson R; Nel AE
    Cancer Res; 1988 Jun; 48(11):3094-9. PubMed ID: 3130185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of benoxaprofen on the binding to and inactivation of leucoattractants by human polymorphonuclear leucocytes in vitro.
    Anderson R; Lukey PT; van Rensburg CE
    Agents Actions; 1985 Sep; 16(6):527-34. PubMed ID: 4072830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of benoxaprofen on mononuclear and polymorphonuclear leucocyte motility. An in vitro and in vivo study.
    Naude SP; Anderson R; Eftychis E; Theron A; van Wyk H; Jooné GK
    S Afr Med J; 1983 Jun; 63(24):926-30. PubMed ID: 6304922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pro-oxidative interactions of flunoxaprofen and benoxaprofen with human polymorphonuclear leucocytes in vitro.
    Van Rensburg AJ; Theron AJ; Anderson R
    Agents Actions; 1991 Jul; 33(3-4):292-9. PubMed ID: 1950816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benoxaprofen activates membrane-associated oxidative metabolism in human polymorphonuclear leucocytes by apparent modulation of protein kinase C.
    Lukey PT; Anderson R; Dippenaar UH
    Br J Pharmacol; 1988 Feb; 93(2):289-94. PubMed ID: 2833969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes.
    Anderson R; Fernandes AC; Eftychis HE
    J Antimicrob Chemother; 1984 Jul; 14(1):41-50. PubMed ID: 6592163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofazimine-mediated stimulation of prostaglandin synthesis and free radical production as novel mechanisms of drug-induced immunosuppression.
    Zeis BM; Anderson R
    Int J Immunopharmacol; 1986; 8(7):731-9. PubMed ID: 3465708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of suppressor mononuclear leucocyte activity by benoxaprofen in vitro.
    Eftychis HA; Anderson R
    S Afr Med J; 1982 Apr; 61(17):609. PubMed ID: 6979104
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune induction of human monocyte plasminogen activator. Characteristics of an assay for cell-mediated immunity.
    Ragsdale CG; Swartz KH; Cassidy JT
    J Immunol Methods; 1985 May; 79(1):13-26. PubMed ID: 2987356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and conA-induced suppressor lymphocytes: a comparative study.
    Gattringer C; Huber H; Michlmayr G; Braunsteiner H
    Immunobiology; 1981; 159(3):293-306. PubMed ID: 6455380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of T cell responses by spontaneously active suppressor cells.
    Dwyer JM; Johnson C
    Clin Exp Immunol; 1982 Nov; 50(2):406-15. PubMed ID: 6217935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dithranol mediates pro-oxidative inhibition of polymorphonuclear leukocyte migration and lymphocyte proliferation.
    Anderson R; Lukey PT; Dippenaar U; Eftychis HA; Findlay GH; Wooten MW; Nel AE
    Br J Dermatol; 1987 Oct; 117(4):405-18. PubMed ID: 3676090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concanavalin A-induced suppressor cell activity in untreated cancer cervix patients.
    Satam MN; Rajpal RM; Nadkarni JJ
    Indian J Med Res; 1986 Jul; 84():62-6. PubMed ID: 2945782
    [No Abstract]   [Full Text] [Related]  

  • 19. Human monocyte-derived soluble product(s) has an accessory function in the generation of histamine- and concanavalin A-induced suppressor T cells.
    Beer DJ; Dinarello CA; Rosenwasser LJ; Rocklin RE
    J Clin Invest; 1982 Aug; 70(2):393-400. PubMed ID: 6212597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vivo and in vitro investigation of the phototoxic potential of tenoxicam, a new non-steroidal anti-inflammatory agent.
    Anderson R; Eftychis HA; Weiner A; Findlay GH
    Dermatologica; 1987; 175(5):229-34. PubMed ID: 3678549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.